PMID: 19142413Jan 15, 2009Paper

Aripiprazole in the treatment of posttraumatic stress disorder: an open-label trial

Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina
Marcelo Feijo MelloJose Paulo Fiks

Abstract

Post traumatic stress disorder is frequent in the general population (7.8%-lifetime-USA). The selective serotonin reuptake inhibitors are the first choice of treatment but result in low remission rates. This study aims to evaluate the effect of aripiprazole monotherapy for the treatment of post traumatic stress disorder. Thirty-two patients diagnosed with post traumatic stress disorder were included in a 16-week open label trial of aripiprazole. They were evaluated at baseline, week 8, and 16 with the Clinician-Administered PTSD Scale, Beck Depression Inventory, Beck Anxiety Inventory, Medical Outcome Study Short Form 36, and Social Adjustment Scale. Statistical analysis were performed with an intention-to-treat approach and last observation carried forward. A general linear model for repeated measures comparing the factor with 3 continuous measures from baseline, 8 and 16 weeks was used. A between-subject factor was included Nine patients discontinued the treatment. The mean aripiprazole dose was 9.6 (+/- 4.3) mg/day. The mean scores at baseline and endpoint for all measures were: Clinician-Administered PTSD Scale - 82.7 (+/- 23.1) and 51.4 (+/- 31.4) (F = 11.247, p = 0.001); Beck Anxiety Inventory - 31.7 (+/- 13.4) and 25.4 (...Continue Reading

References

Jun 1, 1995·The American Journal of Psychiatry·K S KendlerL J Eaves
Apr 19, 2000·JAMA : the Journal of the American Medical Association·K BradyG M Farfel
Feb 13, 2002·The Journal of Clinical Psychiatry·Jeffrey Berlant, Daniel P van Kammen
Jan 28, 2003·Biological Psychiatry·Jonathan R T DavidsonSusan van Meter
Sep 11, 2004·Journal of Psychopharmacology·Tsuyoshi HiroseToshitaka Nabeshima
Mar 2, 2005·Biological Psychiatry·George BartzokisC Scott Saunders
Mar 11, 2006·International Clinical Psychopharmacology·Michael Tedford Lambert
May 17, 2006·Journal of Clinical Psychopharmacology·Jonathan DavidsonJeff J Musgnung
Sep 2, 2006·The International Journal of Neuropsychopharmacology·Dragica Kozaric-Kovacic, Nela Pivac
Sep 13, 2007·The Annals of Pharmacotherapy·Prasad R PadalaSubhash C Bhatia

❮ Previous
Next ❯

Citations

May 28, 2015·Expert Opinion on Emerging Drugs·James W MurroughDennis S Charney
Jul 28, 2012·Expert Opinion on Investigational Drugs·Christopher K CainJohn H Kehne
Feb 25, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Nienke C C VulinkDamiaan Denys
Mar 20, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Chiung-Chi YehVincent C H Chen
Dec 22, 2016·Journal of Clinical Medicine·Mark B DetweilerBrian W Lutgens
Aug 12, 2010·Journal of Psychopharmacology·Caroline BiojoneFabrício A Moreira
Oct 24, 2017·Clinical Neuropharmacology·Sara R BritnellBruce P Capehart
Jan 14, 2010·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Lucas C QuarantiniKarestan C Koenen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.